European Journal of Pharmaceutical Sciences,
Год журнала:
2023,
Номер
190, С. 106554 - 106554
Опубликована: Авг. 3, 2023
The
application
of
Göttingen
minipigs
for
non-rodent
pharmacokinetics
(PK)
and
drug
safety
testing
has
seen
a
dramatic
increase
in
recent
years.
aim
this
study
was
to
determine
the
total
unbound
brain-to-plasma
ratios
(Kp,brain
Kp,uu,brain)
diverse
set
reference
compounds
female
compare
these
with
Kp,uu,brain
values
from
other
species
assess
suitability
as
model
CNS
brain
PK
clinical
translation.
consisted
17
varying
physico-chemical
properties
included
known
human
P-glycoprotein
(P-gp)
substrates.
results
showed,
that
minipig
Kp,brain
tested
were
range
0.03-86
0.02-2.4
(n
=
3-4)
respectively.
comparable
between
rat
large
proportion
(71%
within
2-fold,
n
17).
Comparisons
penetration
across
several
subset
revealed
quite
similar
those
rat,
dog,
monkey
human.
highlighted
largest
differences
observed
classified
transporter
substrates
(e.g.
cimetidine,
risperidone,
Way-100635
altanserin).
In
conclusion
data
add
substantially
available
literature
on
disposition
support
use
candidates
Aging and Disease,
Год журнала:
2023,
Номер
14(6), С. 2193 - 2193
Опубликована: Янв. 1, 2023
Increasing
evidence
has
shown
that
gut
dysbacteriosis
may
play
a
crucial
role
in
neuroinflammation
Parkinson's
disease
(PD).
However,
the
specific
mechanisms
link
microbiota
to
PD
remain
unexplored.
Given
critical
roles
of
blood-brain
barrier
(BBB)
dysfunction
and
mitochondrial
development
PD,
we
aimed
evaluate
interactions
among
microbiota,
BBB,
resistance
oxidation
inflammation
PD.
We
investigated
effects
fecal
transplantation
(FMT)
on
physiopathology
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
(MPTP)-treated
mice.
The
aim
was
explore
from
patients
healthy
human
controls
neuroinflammation,
BBB
components,
antioxidative
capacity
via
AMPK/SOD2
pathway.
Compared
control
mice,
MPTP-treated
mice
exhibited
elevated
levels
Desulfovibrio,
whereas
given
FMT
enriched
Akkermansia
humans
showed
no
significant
alterations
microbiota.
Strikingly,
significantly
aggravated
motor
impairments,
dopaminergic
neurodegeneration,
nigrostriatal
glial
activation
colonic
inflammation,
inhibited
signaling
greatly
improved
aforementioned
MPTP-caused
effects.
Surprisingly,
displayed
loss
pericytes,
which
restored
by
controls.
Our
findings
demonstrate
can
correct
ameliorate
neurodegeneration
MPTP-induced
mouse
model
suppressing
microgliosis
astrogliosis,
ameliorating
impairments
pathway,
restoring
pericytes
integrity.
These
raise
possibility
alteration
be
risk
factor
for
provide
potential
application
preclinical
treatment.
Cells,
Год журнала:
2023,
Номер
12(20), С. 2443 - 2443
Опубликована: Окт. 12, 2023
Proper
functioning
of
the
neural
retina
relies
on
unique
retinal
environment
regulated
by
blood–retinal
barrier
(BRB),
which
restricts
passage
solutes,
fluids,
and
toxic
substances.
BRB
impairment
occurs
in
many
vascular
diseases
breakdown
significantly
contributes
to
disease
pathology.
Understanding
different
molecular
constituents
signaling
pathways
involved
development
maintenance
is
therefore
crucial
developing
treatment
modalities.
This
review
summarizes
major
inner
(iBRB)
formation
maintenance,
representative
animal
models
eye
with
leakage.
Studies
Wnt/β-catenin
are
highlighted,
critical
for
brain
angiogenesis
barriergenesis.
Moreover,
multiple
vivo
vitro
methods
detection
analysis
leakage
described,
along
their
advantages
limitations.
These
pre-clinical
assessing
iBRB
provide
valuable
experimental
tools
delineating
mechanisms
evaluating
therapeutic
drugs.
Scientific Reports,
Год журнала:
2024,
Номер
14(1)
Опубликована: Июль 9, 2024
Abstract
Predicting
the
blood–brain
barrier
(BBB)
permeability
of
small-molecule
compounds
using
a
novel
artificial
intelligence
platform
is
necessary
for
drug
discovery.
Machine
learning
and
large
language
model
on
(AI)
tools
improve
accuracy
shorten
time
new
development.
The
primary
goal
this
research
to
develop
computing
models
deep
architectures
capable
predicting
whether
molecules
can
permeate
human
(BBB).
in
silico
(computational)
vitro
(experimental)
results
were
validated
by
Natural
Products
Research
Laboratories
(NPRL)
at
China
Medical
University
Hospital
(CMUH).
transformer-based
MegaMolBART
was
used
as
simplified
molecular
input
line
entry
system
(SMILES)
encoder
with
an
XGBoost
classifier
method
check
if
molecule
could
cross
through
BBB.
We
Morgan
or
Circular
fingerprints
apply
algorithm
set
atomic
invariants
baseline
also
compare
results.
BBB
assessed
three-dimensional
(3D)
spheroids
(human
brain
microvascular
endothelial
cells,
vascular
pericytes,
astrocytes).
Using
multiple
databases,
final
transformer
achieved
area
under
receiver
operating
characteristic
curve
0.88
held-out
test
dataset.
Temozolomide
(TMZ)
21
randomly
selected
permeable
(Pred
scores
=
1,
indicating
BBB-permeable)
from
NPRL
penetrated
spheroid
cells.
No
evidence
suggests
that
ferulic
acid
five
BBB-impermeable
<
1.29423E−05,
which
designate
pass
BBB)
cells
Our
validation
experiments
indicated
prediction
permeation
accurate.
Transformer-based
like
MegaMolBART,
leveraging
SMILES
representations
molecules,
show
great
promise
applications
These
have
potential
accelerate
development
targeted
treatments
disorders
central
nervous
system.
Current Research in Biotechnology,
Год журнала:
2024,
Номер
8, С. 100235 - 100235
Опубликована: Янв. 1, 2024
Neuropharmacology
faces
challenges
due
to
the
intricate
nervous
system,
diverse
neurological
disorders,
and
existence
of
blood–brain
barrier
(BBB),
which
hinder
development
effective
treatments.
Although
primary
function
BBB
is
expel
toxins
pathogens,
this
structure
also
prevents
optimal
drug
delivery.
Natural
products,
with
their
chemical
diversity
sustainability,
have
long
been
recognized
as
potential
neuroprotective
compounds,
making
permeability
studies
mandatory.
Over
last
ten
years,
biotechnological
advances
in
two-dimensional
vitro
models
(monoculture
co-culture),
vivo
imaging
techniques,
pharmacokinetic
modeling
contributed
expanding
our
current
knowledge.
In
study,
we
reviewed
crossing
natural
products
such
different
terpenoids,
polyphenolic
alkaloids.
The
findings,
obtained
through
vitro,
vivo,
silico
methods,
revealed
moderate
high
for
many
these
products.
However,
other
compounds
showed
not
be
able
reach
brain.
To
better
understand
behavior
humans
improve
ability
pass
across
blood-brainier,
new
three-dimensional
dynamic
BBB,
nanosystems
complexes
encapsulation
or
in-depth
transport
mechanism
are
future
lines
research.
Advanced Healthcare Materials,
Год журнала:
2024,
Номер
13(21)
Опубликована: Март 2, 2024
Abstract
The
blood‐brain
barrier
(BBB)
is
a
highly
controlled
microenvironment
that
regulates
the
interactions
between
cerebral
blood
and
brain
tissue.
Due
to
its
selectivity,
many
therapeutics
targeting
various
neurological
disorders
are
not
able
penetrate
into
Pre‐clinical
studies
using
animals
other
in
vitro
platforms
have
shown
ability
fully
replicate
human
BBB
leading
failure
of
majority
clinical
trials.
However,
recent
innovations
ex
vivo
modeling
called
organs‐on‐chips
potential
create
more
accurate
disease
models
for
improved
drug
development.
These
microfluidic
induce
physiological
stressors
on
cultured
cells
generate
physiologically
BBBs
compared
previous
models.
In
this
review,
different
approaches
BBBs‐on‐chips
explored
alongside
their
application
therapeutic
efficacy.
Additionally,
use
delivery
discussed,
advances
linking
onto
multiorgan
mimic
organ
crosstalk
reviewed.
Frontiers in Aging Neuroscience,
Год журнала:
2023,
Номер
15
Опубликована: Апрель 17, 2023
The
blood-brain
barrier
(BBB)
consists
of
specialized
cells
that
tightly
regulate
the
in-
and
outflow
molecules
from
blood
to
brain
parenchyma,
protecting
brain’s
microenvironment.
If
one
BBB
components
starts
fail,
its
dysfunction
can
lead
a
cascade
neuroinflammatory
events
leading
neuronal
degeneration.
Preliminary
imaging
findings
suggest
could
serve
as
an
early
diagnostic
prognostic
biomarker
for
number
neurological
diseases.
This
review
aims
provide
clinicians
with
overview
emerging
field
in
humans
by
answering
three
key
questions:
(1.
Disease)
In
which
diseases
be
useful?
(2.
Device)
What
are
currently
available
methods
evaluating
integrity?
And
(3.
Distribution)
what
is
potential
different
environments,
particularly
resource
limited
settings?
We
conclude
further
advances
needed,
such
validation,
standardization
implementation
readily
available,
low-cost
non-contrast
techniques,
useful
clinical
both
resource-limited
well-resourced
settings.
Pharmaceutics,
Год журнала:
2024,
Номер
16(5), С. 574 - 574
Опубликована: Апрель 23, 2024
The
blood-brain-barrier
(BBB)
is
made
up
of
blood
vessels
whose
permeability
enables
the
passage
some
compounds.
A
predictive
model
BBB
important
in
early
stages
drug
development.
predicted
permeabilities
drugs
have
been
confirmed
using
a
variety
vitro
methods
to
reduce
quantities
candidates
needed
preclinical
and
clinical
trials.
Most
prior
studies
relied
on
animal
or
cell-culture
models,
which
do
not
fully
recapitulate
human
BBB.
development
microfluidic
models
human-derived
cells
could
address
this
issue.
We
analyzed
for
predicting
Emulate
BBB-on-a-chip
machine.
Ten
compounds
were
evaluated,
their
estimated.
Our
study
demonstrated
that
trends
ten
our
microfluidic-based
system
resembled
those
observed
previous
cell-based
experiments.
Furthermore,
we
established
general
correlation
between
partition
coefficient
(Kp)
apparent
(Papp).
In
conclusion,
introduced
new
paradigm
systems.
Journal of Neuroinflammation,
Год журнала:
2024,
Номер
21(1)
Опубликована: Июнь 6, 2024
Abstract
Central
nervous
system
infections
have
been
suggested
as
a
possible
cause
for
neurodegenerative
diseases,
particularly
sporadic
cases.
They
trigger
neuroinflammation
which
is
considered
integrally
involved
in
processes.
In
this
review,
we
will
look
at
data
linking
variety
of
viral,
bacterial,
fungal,
and
protozoan
to
Alzheimer’s
disease,
Parkinson’s
amyotrophic
lateral
sclerosis,
multiple
sclerosis
unspecified
dementia.
This
narrative
review
aims
bring
together
broad
range
currently
supporting
the
involvement
central
development
diseases.
The
idea
that
no
single
pathogen
or
group
responsible
diseases
be
discussed.
Instead,
suggest
wide
susceptibility
factors
may
make
individuals
differentially
vulnerable
different
infectious
pathogens
subsequent
pathologies.
Pneumonia
is
a
common
infection
in
people
suffering
with
Alzheimer's
disease,
leading
to
delirium,
critical
illness
or
severe
neurological
decline,
which
may
be
due
an
amplified
response
of
the
blood-brain
barrier
(BBB)
peripheral
insult.
We
assess
BBB
repeated
Streptococcus
pneumoniae
lung
rat
model
disease
(TgF344-AD),
at
13-
and
18-months
old,
using
dynamic
contrast-enhanced
(DCE)
MRI
filter
exchange
imaging.
Higher
water
rate
initially
detected
infected
TgF344-AD
rats.
rates
correlated
hippocampus
aquaporin-4
channel
expression
animals.
no
differences
permeability
gadolinium
contrast
agent
measured
by
DCE-MRI,
confirmed
staining
for
tight
junction
proteins,
occludin
claudin-5.
These
findings
provide
insight
into
mechanisms
how
inflammation
impacts
BBB.